Guanhao Biotech Co Ltd (300238)

Currency in CNY
17.65
-0.63(-3.45%)
Closed·

300238 Financial Summary

Key Ratios

P/E Ratio157.31
Price/Book7.9
Debt / Equity26.63%
Return on Equity3.3%
Dividend Yield0.00%
EBITDA55.60M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2022
01/01
2023
01/01
2023
31/12
2024
31/12
* In Millions of CNY (except for per share items)

Earnings

Latest Release
Apr 22, 2025
EPS / Forecast
0.06 / --
Revenue / Forecast
94.80M / --
EPS Revisions
Last 90 days

FAQ

What were Guanhao Biotech's earnings for the latest quarter?

The Guanhao Biotech EPS (TTM) is 0.11. Guanhao Biotech reported sales of 94.80, net income of 14.87, and EPS of 0.06 for the latest quarter.

What was Guanhao Biotech's net income for the latest quarter?

Guanhao Biotech's net income for the latest quarter was 14.87.

How did Guanhao Biotech's performance compare year-over-year in the latest quarter?

The company's revenue moved from 99.35 in the previous quarter to 94.80 in the latest quarter, and net income moved from -0.42 to 14.87 compared to the previous quarter.

What is Guanhao Biotech's net profit margin on a TTM basis?

Guanhao Biotech's trailing twelve months (TTM) net profit margin is 7.26%.

How does Guanhao Biotech's debt to equity ratio compare to industry standards?

Guanhao Biotech's total debt-to-equity ratio is 26.63%.

What is Guanhao Biotech's return on investment on a TTM basis?

Guanhao Biotech's trailing twelve months (TTM) return on investment (ROI) is 3.30%.

Did Guanhao Biotech gain or lose cash last quarter?

In the latest quarter, Guanhao Biotech's net change in cash was 17.37 million.

What were Guanhao Biotech's total assets and liabilities in the latest quarter?

As of the latest quarter, Guanhao Biotech reported total assets of 764.24 million and total liabilities of 145.96 million.

How has Guanhao Biotech's total revenue grown this year?

Guanhao Biotech's total revenue was 99.35 in the previous quarter and 94.80 in the latest quarter.

What is Guanhao Biotech's gross margin on a TTM basis?

Guanhao Biotech's trailing twelve months (TTM) gross margin is 78.86%.

What was Guanhao Biotech's revenue per share for the latest quarter?

Guanhao Biotech's revenue per share for the latest quarter was 6.36.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.